Development of a prognostic signature for bladder cancer based on immune-related genes

BACKGROUND: Although the prognosis of patients with bladder cancer (BC) has improved significantly with the use of multimodal therapy, reliable prognostic biomarkers are still urgently needed due to the heterogeneity of tumors. Our aim was to develop an individualized immune-related gene pair (IRGP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ying-Rui, Xiong, Kun, Ye, Xu, Yang, Pei, Wu, Zheng, Zu, Xiong-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723522/
https://www.ncbi.nlm.nih.gov/pubmed/33313125
http://dx.doi.org/10.21037/atm-20-1102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723522/
https://www.ncbi.nlm.nih.gov/pubmed/33313125
http://dx.doi.org/10.21037/atm-20-1102

Ejemplares similares